PAR-20-084 - NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
| Notice of Participation of the National Institute on Aging (NIA) in PAR-20-084 "NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)" |
NOT-AG-22-019 |
NIA |
Mar 11, 2022 |
Sep 8, 2026 |
R21 |
Expired NOSIs
| Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
| Notice of Special Interest (NOSI): Technological Innovations for Advancing Clinical SPECT Imaging |
NOT-EB-22-006 |
NIBIB |
Mar 21, 2022 |
May 8, 2024 |
R21, F30, K01, R13, K23, K25, R43/R44, K08, R01, K99/R00, R41/R42, F32, R03, F31 |
| Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition |
NOT-HD-21-027 |
NICHD, NIAAA, NCI, NIMH, NIAMS, OBSSR, NIBIB, NIDCR |
Jun 22, 2021 |
Jan 8, 2024 |
R01, R21, R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) |
NOT-EB-20-007 |
NIBIB |
Apr 10, 2020 |
Aug 29, 2020 |
R01, R21, R03 |
An official website of the United States government
